简体中文 | 繁體中文 | English

Press Releases

2024-06-19 09:53 Seoul Viosys Files LED Patent Lawsuit Against U.S. Home Lighting Company
2024-06-19 09:50 NTT DATA, Inc. Appoints Abhijit Dubey as Chief Executive Officer
2024-06-19 09:33 Medidata Launches Clinical Data Studio, Leveraging AI to Modernize the Data Experience in Clinical Trials
2024-06-18 20:13 Enthusiastic Visitors from Around the World Come to See a Life-Size Godzilla. Total Visitors to Tokyo Night & Light, the World's Largest Projection Mapping Show, Has Exceeded 200,000! Content Presented in Japanese-style "Ukiyo" Also Appears On-screen
2024-06-18 14:00 Carestream Secures Crucial Business Partner Agreement in Peru
2024-06-18 12:54 Cognite Atlas AI™ Delivers Specialized Industrial Agents, Virtual Employees Tailored to Provide Domain-Specific Insights and Automate Complex Industrial Tasks
2024-06-18 12:49 Dubai becomes the world metropolis for artificial intelligence
2024-06-18 12:39 A Spectacle in NYC: Empire State Building Debuts 270-Foot Vhagar the Dragon Coiled Around the Building’s Mast, in Partnership with Max
2024-06-18 09:45 Takeda Announces Phase 3 Topline Results for Soticlestat (TAK-935) in Patients with Dravet Syndrome and Lennox-Gastaut Syndrome
2024-06-17 12:48 VCTC Kicks Off Plugfest to Advance Digital Keys by Enhancing Ultra-Wideband Technology
2024-06-17 11:39 Argonne and a Moroccan University Sign Agreement to Advance Green Energy Tech and Computing
2024-06-17 11:35 Kirin Holdings Commences Tender Offer To Make FANCL A Wholly-Owned Subsidiary
2024-06-17 11:24 MultiBank Group Recognized as Top BaFin-Regulated Forex Broker
2024-06-17 11:20 SLB and Aker Carbon Capture Announce Closing of Carbon Capture Joint Venture
2024-06-17 11:10 Eaton's Innovative Safety Solutions Help Accelerate Electrified Vehicle Transition
2024-06-17 10:09 Takeda Signs Option Agreement with Ascentage Pharma to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI)
2024-06-14 16:29 Celltrion showcases promising results in phase III study for CT-P47, a biosimilar candidate of RoActemra® (tocilizumab) in patients with rheumatoid arthritis (RA) at EULAR 2024
2024-06-14 10:49 Brightcove to Power FrightPix, a New Streaming Destination for Horror, Thriller and True Crime Fans
2024-06-14 10:21 80% of Organizations Agree That Inadequate or Outdated Technology Is Holding Back Innovation
2024-06-14 10:05 WORLDCOM AWARD 2024 in Tokyo Held on Jun 5, 2024

Business Wire Weibo

Industries

Latest Releases